Inventor
XIAOKAI LI
Inventor
US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G02Fprimary
G02FOptical devices or arrangements for the control of light by modification of the optical properties of the media of the elements involved therein21%
A61KPreparations for medical, dental or toiletry purposes11%
C12NMicroorganisms or enzymes11%
G02BOptical elements, systems or apparatus11%
G09GArrangements or circuits for control of indicating devices using static means to present variable information11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%
B60JWindows, windscreens, non-fixed roofs, doors, or similar devices for vehicles6%
C07DHeterocyclic compounds6%
C07KPeptides3%
G06FElectric digital data processing3%
PatentTitleYear
12,593,121Method, apparatus, device and storage medium for image processing202612,582,718Integrin targeting ligands and uses thereof202612,583,858TDO2 inhibitors202612,551,569RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of use202612,535,708Optical systems having polarization recycling structures202612,503,696RNAi agents for inhibiting expression of inhibin subunit beta E (INHBE), pharmaceutical compositions thereof, and methods of use202512,449,668Head-mounted display device and control method thereof, computer-readable storage medium202512,405,502Pixel layouts for electronic device displays202512,378,558RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutical compositions thereof, and methods of use202512,221,610RNAi agents for inhibiting expression of HIF-2 alpha (202512,090,821Systems with adjustable window transmission202412,007,639Systems with adjustable window transmission and haze202411,927,864Optical systems having fLCOS display panels202411,922,867Motion corrected interleaving202411,912,997RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use202411,845,937RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use202311,829,039Optical systems with green-heavy illumination sequences for fLCOS display panels202311,822,083Display system with time interleaving202311,822,191Display system with localized optical adjustments202311,804,197Optical systems having overdriven fLCOS display panels202311,796,872Optical systems with pixel shifting structures202311,778,858Electronic device displays having microlenses202311,762,197Display systems with geometrical phase lenses202311,754,886Pixel layouts for electronic device displays202311,693,279Adjustable windows202311,605,330Mitigation of tearing from intra-frame pause202311,598,985Systems with adjustable window transmission and haze202311,597,701Integrin ligands and uses thereof202311,521,563Techniques to compensate for flicker at low refresh rates202211,232,745Multi-frame buffer for pixel drive compensation2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to APPLE INC (19)· patent assignee history
2022–2026Based in US· patent location history
2023–2026Patents assigned to ARROWHEAD PHARMACEUTICALS INC (8)· patent assignee history
2025–2026Patents assigned to BEIJING ZITIAO NETWORK TECHNOLOGY CO LTD (2)· patent assignee history
2025–2026Based in CN· patent location history
2026Patents assigned to GENENTECH INC (1)· patent assignee history
2026Patents assigned to LEMON INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| APPLE INC | 19 | 2022–2026 |
| ARROWHEAD PHARMACEUTICALS INC | 8 | 2023–2026 |
| BEIJING ZITIAO NETWORK TECHNOLOGY CO LTD | 2 | 2025–2026 |
| GENENTECH INC | 1 | 2026 |
| LEMON INC | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 28 | 2022–2026 |
| CN | 2 | 2025–2026 |